Antidepressive treatment with amitriptyline and paroxetine: effects on saliva cortisol concentrations

J Clin Psychopharmacol. 2003 Apr;23(2):201-5. doi: 10.1097/00004714-200304000-00014.

Abstract

With regard to the course of basal human hypothalamus-pituitary-adrenal (HPA) system activity, there is a lack of data for comparing different classes of antidepressants. Ninety-four patients were included in a study comparing standardized treatment with paroxetine (PAROX) and amitriptyline (AMI) after a drug-free period of at least 6 days. Saliva for measurement of cortisol concentrations was obtained daily at 0800, 1600, and 2200 during the 6 days of drug-free washout and 35 days of active treatment. The course of HPA system activity and psychopathology, as assessed by the Hamilton Depression Scale, was compared by means of repeated-measurement analyses of variance (ANOVA-rm). Only AMI responders-not PAROX responders or nonresponders to either antidepressant-had a significant decline in saliva cortisol concentrations. In hypercortisolemically depressed patients, treatment with AMI may be preferable to PAROX in order to lower HPA system activity.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amitriptyline / pharmacology*
  • Amitriptyline / therapeutic use
  • Antidepressive Agents / pharmacology*
  • Antidepressive Agents / therapeutic use
  • Depressive Disorder, Major / drug therapy*
  • Depressive Disorder, Major / physiopathology
  • Depressive Disorder, Major / psychology
  • Female
  • Humans
  • Hydrocortisone / analysis*
  • Hypothalamo-Hypophyseal System / drug effects
  • Hypothalamo-Hypophyseal System / physiopathology
  • Male
  • Middle Aged
  • Paroxetine / pharmacology*
  • Paroxetine / therapeutic use
  • Pituitary-Adrenal System / drug effects
  • Pituitary-Adrenal System / physiopathology
  • Psychiatric Status Rating Scales
  • Saliva / chemistry*
  • Treatment Outcome

Substances

  • Antidepressive Agents
  • Amitriptyline
  • Paroxetine
  • Hydrocortisone